stockrowHims & Hers Health, Inc. (HIMS) vs Indivior Pharmaceuticals Inc. (SUPN)
- Hims & Hers Health, Inc. HIMS 24.11 −9.56%
- Indivior Pharmaceuticals Inc. SUPN 28.21 +0.21%
Hims & Hers Health, Inc. and Indivior Pharmaceuticals Inc. are both Drug Manufacturers Specialty & Generic companies. Hims & Hers Health, Inc. and Indivior Pharmaceuticals Inc. are of similar size ($5.6B and $5.6B). Hims & Hers Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Indivior Pharmaceuticals Inc. trades at 7.6×. Hims & Hers Health, Inc. grew revenue faster over the last twelve months: 28.0% against 16.4%. Indivior Pharmaceuticals Inc. has the higher net margin (32.9% vs −5.51%) and the higher return on invested capital (283.0% vs −11.4%). Across the 18 metrics below, Hims & Hers Health, Inc. leads on 9 and Indivior Pharmaceuticals Inc. on 9.
Valuation
Profitability
| Metric | HIMS | SUPN | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 68.43% | 84.85% | 53.51% |
| Operating margin | (5.99%) | 40.57% | 0.00% |
| Net margin | (5.51%) | 32.85% | (2.45%) |
| Free cash flow margin | 3.22% | 2.26% | 0.00% |
| Return on equity | (32.03%) | (337.83%) | (0.80%) |
| Return on assets | (5.16%) | 32.82% | (1.67%) |
| Return on invested capital | (11.38%) | 283.03% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack